icthiovac vnn
laboratorios hipra s.a. - virus della redspotted grouper nervous necrosis (betanodavirus rgnnv), virus della redspotted grouper nervous necrosis (betanodavirus rgnnv) - virus della redspotted grouper nervous necrosis (betanodavirus rgnnv) - 60 dose; virus della redspotted grouper nervous necrosis (betanodavirus rgnnv) - nd, - - pisces, others
procactive
laboratorios syva sau - benzil-penicillina procaina - benzil-penicillina procaina - 300 mg/ml, benzil-penicillina procainica - 300 mg/ml - procaine benzilpenicillin
inmeva
laboratorios hipra s.a. - chlamydia abortus, ceppo a22, inattivato, salmonella enterica, sierovariante abortusovis, ceppo sao, inattivato - chlamydia abortus; ceppo a22; inattivato - 1 r.p. - potency relativa; salmonella enterica; sierovariante abortusovis; ceppo sao; inattivato - nd, chlamydophila abortus - 1 r.p. - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
nasym
laboratorios hipra s.a. - vivo attenuato virus respiratorio sinciziale bovino (brsv), ceppo lym-56 - prodotti immunologici per bovidae, bestiame, live virali vaccini, virus respiratorio sinciziale bovino (brsv) - bestiame - immunizzazione attiva dei bovini per ridurre spargimento del virus respiratori e segni clinici causati da virus respiratorio sinciziale bovino infezione.
condroitina solfato rovi
laboratorios farmaceuticos rovi s.a. - condroitinsolfato - condroitinsolfato
citramox 1000 mg/g polvere per uso in acqua da bere
laboratorios karizoo s.a. - amoxicillina triidrato - orale - amoxicillina triidrato - nd, amoxicillina triidrato (fu) 1000 mg/g - amoxicillin - avicoli, suini
mhyosphere pcv id
laboratorios hipra s.a. - proteina capsidica di circovirus suino di tipo 2(pcv2), mycoplasma hyopneumoniae inattivato - proteina capsidica di circovirus suino di tipo 2(pcv2) - 1.3 u. elisa; mycoplasma hyopneumoniae inattivato - 1.3 u. elisa - porcine circovirus + mycoplasma
halofusol
laboratorios karizoo s.a. - halofuginone lactate - orale - halofuginone lactate - nd, alofuginone 0,5 mg/ml - halofuginone - vitelli
icthiovac vr concentrato per sospensione per immersione/iniettabile per spigola e rombo.
laboratorios hipra s.a. - vibrio (listonella) anguillarum, sierotipo o2beta, inattivato, vibrio (listonella) anguillarum, sierotipo o2alfa, inattivato, vibrio (listonella) anguillarum, sierotipo o1, inattivato - altro, iniettabile - vibrio (listonella) anguillarum; sierotipo o2beta; inattivato - 60 percentuale relativa di sopravvivenza; vibrio (listonella) anguillarum; sierotipo o2alfa; inattivato - 60 percentuale relativa di sopravvivenza; vibrio (listonella) anguillarum; sierotipo o1; inattivato - 60 percentuale relativa di sopravvivenza, vaccino vibrio anguillarum inattivato - pisces, others - pesci
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.